Sudden Recanalization: A Game-Changing Factor in Endovascular Treatment of Large Vessel Occlusion Strokes.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 23 2 2020
medline: 17 9 2020
entrez: 21 2 2020
Statut: ppublish

Résumé

Background and Purpose- First pass (FP) recanalization has been shown to be a predictor of favorable outcome in endovascular treatment of stroke. The reasons why FP recanalization leads to better outcome as compared with multiple passes (MP) are unknown. We aim to investigate the recanalization pattern and its relationship with outcome. Methods- Six hundred nine consecutive patients underwent endovascular treatment. Recanalization was defined as modified Thrombolysis in Cerebral Infarction score 2B-3. Favorable outcome was defined as modified Rankin Scale score of 0 to 2 at 90 days. Sudden recanalization (SR) was considered when modified Thrombolysis in Cerebral Infarction score varied from 0-1 to 2B-3 in a single pass. Progressive recanalization (PR) was considered if modified Thrombolysis in Cerebral Infarction score 2A was achieved at an interim pass before achieving recanalization. Patients were also categorized as recanalizers at FP, MP, or nonrecanalizers. Results- Five hundred nine (83.9%) patients achieved recanalization. SR was achieved in 378 (62.1%) patients; 280 (46%) were FP-SR, and 98 (16.1%) were MP-SR. MP-PR was achieved in 131 (21.5%) patients. Rates of favorable outcome were similar between patients with FP-SR (57.5%) and MP-SR (57.1%; odds ratio [OR], 0.9 [CI, 0.53-1.54];

Identifiants

pubmed: 32078495
doi: 10.1161/STROKEAHA.119.028787
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1313-1316

Auteurs

Álvaro García-Tornel (Á)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Marta Rubiera (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Manuel Requena (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Marian Muchada (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Jorge Pagola (J)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

David Rodriguez-Luna (D)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Matias Deck (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Jesus Juega (J)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Noelia Rodríguez-Villatoro (N)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Sandra Boned (S)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Marta Olivé-Gadea (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Alejandro Tomasello (A)

Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.

Carlos Piñana (C)

Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.

David Hernández (D)

Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.

Carlos A Molina (CA)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Marc Ribo (M)

From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d'Hebron, Barcelona, Spain.
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH